Inoviv
Entrepreneur First '18London, GB · Founded 2018 · 4 known investors
Inoviv provides custom multiplexed LC-MS proteomics panels for biomarker discovery and analysis in drug discovery and development. The company delivers pre-validated mass spectrometry workflows with end-to-end support for research and clinical applications.
Founders & leadership
Inoviv was founded in 2018 by Ernestas Sirka.
ES
Ernestas SirkainCSOErnestas Sirka completed a Master's in Molecular and Cellular Biology at the University of Bath with First Class Honours. He conducted formulation research at Pfizer before moving into translational biomarker research at University College London.
MD
Michael DoveinFounding CEOMichael Dove is a graduate of the University of Leeds who started out as a consultant in Accenture's Life Sciences practice. He specializes in deploying technology across the life sciences sector and has supported R&D efforts at several of the world's leading pharmaceutical firms.
Investors · 4
Competitors · 2
by search overlapInvivyd5 shared keywordsInvivyd develops monoclonal antibody medicines for the prevention and treatment of serious viral infectious diseases, starting with COVID-19 and other high-need indications. It uses a proprietary integrated technology platform to design antibodies that are more potent and resistant to viral evolution.
Stocktwits3 shared keywordsStocktwits is a social platform for investors and traders to share market news, discussions, sentiment polls, and live financial content. It aggregates breaking market news, equity coverage, and community discussions around individual stocks and crypto.
Companies competing with Inoviv for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Inoviv do?
- Inoviv provides custom multiplexed LC-MS proteomics panels for biomarker discovery and analysis in drug discovery and development. The company delivers pre-validated mass spectrometry workflows with end-to-end support for research and clinical applications.
- Who founded Inoviv?
- Inoviv was founded by Ernestas Sirka in 2018.
- Who are Inoviv's investors?
- Inoviv's investors include Beast Ventures, Entrepreneur First, Hoxton Ventures, Foresight Group.
- Where is Inoviv headquartered?
- Inoviv is headquartered in London, GB.